SeaBeLife is a biotechnology company developing innovative small molecules that simultaneously target two major regulated cell death pathways - necroptosis and ferroptosis - designed to address major unmet medical needs in acute, rare and chronic indications
SeaBeLife is a biotechnology company developing innovative small molecules that simultaneously target two major regulated cell death pathways - necroptosis and ferroptosis - designed to address major unmet medical needs in acute, rare and chronic indications.
SeaBeLife is a biotechnology company developing innovative small molecules that simultaneously target two major regulated cell death pathways - necroptosis and ferroptosis - designed to address major unmet medical needs in acute, rare and chronic indications
SeaBeLife is a biotechnology company developing innovative small molecules that simultaneously target two major regulated cell death pathways - necroptosis and ferroptosis - designed to address major unmet medical needs in acute, rare and chronic indications.